Universe Pharmaceuticals Inc.
UPC · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.7% | -21.3% | -6.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.6% | 27.9% | 25.2% | 29.4% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -31.5% | 46.3% | -93.5% | -27.5% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -35.9% | 43.1% | -101.7% | -39.4% |
| EPS Diluted | -944.4 | 719.79 | -2,155.91 | -919.74 |
| % Growth | -231.2% | 133.4% | -134.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |